Abstract

We read with great interest the article by He et al , which the authors reported that mesenchymal stem cell (MSC) transplantation (MSCT) plus interferon-γ (IFN-γ) combination therapy may realise...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis
Xiang Xu ... Wei Xing
Annals of the Rheumatic Diseases | VOL. 79
Xiang Xu, et. al.Xiang Xu ... Wei Xing
19 Jun 2020
Study on human umbilical cord mesenchymal stem cells transplantation in treatment of stress urinary incontinence in rats LUO Xin*,YAO Run-si,SONG Hong,JIANG Xue-feng,LAN Jian-fa,SHUAI Han-lin,WANG Xiao-yu,LI Rui-man,LIU Qiu-ying,WANG Yi-fei.
-
25 Aug 2013
The influence of human umbilical cord mesenchymal stem cells transplantation into vitreous cavity of diabetic rats on retinal morphology and the expression level of glial fibrillary acidic protein and rhodopsin
...
Chinese Journal of Ocular Fundus Diseases | VOL. 32
, et. al. ...
25 Nov 2016
Response to: ‘Correspondence to: ‘Combination of human umbilical cord mesenchymal stem cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis’’ by Ma et al
Xiang Xu ... Mengwei Yao
Annals of the Rheumatic Diseases | VOL. 81
Xiang Xu, et. al.Xiang Xu ... Mengwei Yao
07 Oct 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers